All mice strains were administrated with probenecid, 200 mg/kg, by oral route in 1% methylcellulose, prior to the administration by subcutaneous route of a formulation of 5%DMSO/20%Encapsin/PEG containing meropenem, amoxicillin and lithium clauvulanate at 300 mg/kg, 200 mg/kg and 50 mg/kg, respectively. In order to study the pharmacokinetic behavior, blood samples of 20 µL were taken from the lateral tail vein at different sampling times (0.5, 1, 2, 4, 6, 8 and 24 h) after subcutaneous administration. Whole blood was mixed with the same volume of water (1:1) in order to facilitate cellular lysis. Samples were frozen at -80ºC until analyzed. Blood samples were extracted by protein precipitation with AcN:MeOH (80:20) before they were analyzed by LC/MS/MS. A chromatographic gradient of formic acid 0.1%/AcN in a HSS 13 50x2.1x1.8 mm column was used with a sensitivity of LLQ = 1-5 ng/ml in 20 µL of blood. Only meropenem was analysed in blood samples. The noncompartmental data analysis (NCA) was performed with WinNonlin 6.3 (Pharsight, Certara L.P).
background). All mice were allowed to acclimate for one week and kept under controlled conditions in a P3 high security facility with sterile food and water ad libitum.
In brief, groups of 4-5 mice were intra-tracheally infected with 100.000 CFU/mouse (M.
tuberculosis H 37 Rv strain). Products were administered for 8 consecutive days (multiple dosing) plus one dose on day 9 th starting 10-12 days after infection. Due to slight differences between the different stock preparations used to inoculate H37Rv, the incubation times were adjusted (between 10 and 12 days) to ensure the same CFU burden (circa 10 7 ) at treatment start. Lungs were harvested 24 hours after the last administration except for some mice as detailed in the figure legend. For the chronic assay kinetics, mice were intra-tracheally infected with 100 CFU/mouse and left untreated until the time-points shown in the graph. All lung lobes were aseptically removed, homogenized and frozen. Homogenates were unfrozen and inmediatly plated in 10% OADC-7H11 medium supplemented with 0.4% activated charcoal, to avoid product carry over, and incubated for 18 days at 37ºC.
Mice were supervised every day under a protocol paying attention to weight loss, apparent good health (bristled hair and wounded skin) and behavior (signs of aggressiveness or isolation). Animals were euthanized by CO2 inhalation. All animal studies were ethically reviewed and carried out in accordance with European Directive 2010/63/EU and the GSK Policy on the Care, Welfare and Treatment of Animals.
Statistical analysis
Statistical comparison between groups was performed by ANOVA and Dunnett's posttest compared to untreated mice (sacrificed at the end of the treatment period) using ANOVA, Dunnett's postest.
